• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

更正：淋巴细胞减少症可预测COVID-19的疾病严重程度：一项描述性和预测性研究。

Correction: Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.

作者信息

Tan Li, Wang Qi, Zhang Duanyang, Ding Jinya, Huang Qianchuan, Tang Yi-Quan, Wang Qiongshu, Miao Hongming

机构信息

Department of Disease Control and Prevention, General Hospital of Central Theater Command, 430015 Wuhan, Hubei province People's Republic of China.

Department of Laboratory, General Hospital of Central Theater Command, 430015 Wuhan, Hubei province People's Republic of China.

出版信息

Signal Transduct Target Ther. 2020 Apr 29;5(1):61. doi: 10.1038/s41392-020-0159-1. eCollection 2020.

DOI:10.1038/s41392-020-0159-1
PMID:32377400
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7189020/
Abstract

[This corrects the article DOI: 10.1038/s41392-020-0148-4.].

摘要

[本文更正了文章的数字对象标识符：10.1038/s41392-020-0148-4。]

相似文献

1
Correction: Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.更正：淋巴细胞减少症可预测COVID-19的疾病严重程度：一项描述性和预测性研究。
Signal Transduct Target Ther. 2020 Apr 29;5(1):61. doi: 10.1038/s41392-020-0159-1. eCollection 2020.
2
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.淋巴细胞减少症可预测新型冠状病毒肺炎的疾病严重程度：一项描述性和预测性研究。
Signal Transduct Target Ther. 2020 Mar 27;5(1):33. doi: 10.1038/s41392-020-0148-4.
3
Erratum: Author Correction: History and progress of hypotheses and clinical trials for Alzheimer's disease.勘误：作者更正：阿尔茨海默病假说与临床试验的历史及进展
Signal Transduct Target Ther. 2019 Sep 23;4:37. doi: 10.1038/s41392-019-0071-8. eCollection 2019.
4
Erratum: Publisher Correction to: Multiple articles in Food Science and Biotechnology.勘误：《食品科学与生物技术》多篇文章的出版商更正。
Food Sci Biotechnol. 2018 Jun 12;27(4):1245. doi: 10.1007/s10068-018-0398-x. eCollection 2018 Aug.
5
Erratum: Publisher Correction: articles initially published in wrong volume.勘误：出版商更正：文章最初发表于错误卷期。
Cell Death Discov. 2019 Jul 10;5:116. doi: 10.1038/s41420-019-0186-2. eCollection 2019.
6
Correction: Community Mitigation of COVID-19 and Portrayal of Testing on TikTok: Descriptive Study.更正：TikTok上新冠病毒病的社区缓解措施及检测情况描述性研究
JMIR Public Health Surveill. 2021 Jun 29;7(6):e31542. doi: 10.2196/31542.
7
Apoptosis-induced T-cell lymphopenia is related to COVID-19 severity.细胞凋亡诱导的 T 细胞淋巴细胞减少与 COVID-19 严重程度有关。
J Med Virol. 2021 May;93(5):2867-2874. doi: 10.1002/jmv.26742. Epub 2021 Feb 23.
8
Lymphopenia as a Biological Predictor of Outcomes in COVID-19 Patients: A Nationwide Cohort Study.淋巴细胞减少作为COVID-19患者预后的生物学预测指标：一项全国性队列研究。
Cancers (Basel). 2021 Jan 26;13(3):471. doi: 10.3390/cancers13030471.
9
Lymphopenia predicted illness severity and recovery in patients with COVID-19: A single-center, retrospective study.淋巴细胞减少症预测 COVID-19 患者的疾病严重程度和恢复情况：一项单中心、回顾性研究。
PLoS One. 2020 Nov 18;15(11):e0241659. doi: 10.1371/journal.pone.0241659. eCollection 2020.
10
Prostaglandin D as a mediator of lymphopenia and a therapeutic target in COVID-19 disease.前列腺素 D 作为 COVID-19 疾病中淋巴细胞减少症的介质和治疗靶点。
Med Hypotheses. 2020 Oct;143:110122. doi: 10.1016/j.mehy.2020.110122. Epub 2020 Jul 21.

引用本文的文献

1
The association between chronic underlying diseases and the clinical characteristics in adult patients infected with Omicron BA.1.成人感染奥密克戎BA.1毒株的慢性基础疾病与临床特征之间的关联
J Virus Erad. 2025 Mar 14;11(2):100591. doi: 10.1016/j.jve.2025.100591. eCollection 2025 Jun.
2
Sulfated Bile Acids in Serum as Potential Biomarkers of Disease Severity and Mortality in COVID-19.血清中硫酸化胆汁酸可作为 COVID-19 疾病严重程度和死亡率的潜在生物标志物。
Cells. 2024 Sep 19;13(18):1576. doi: 10.3390/cells13181576.
3
Analysis of transcriptomics data from COVID-19 patients: a pilot research.新冠肺炎患者转录组学数据分析：一项初步研究。
Folia Microbiol (Praha). 2024 Feb;69(1):155-164. doi: 10.1007/s12223-024-01130-x. Epub 2024 Jan 19.
4
Pathological Effects of SARS-CoV-2 Associated with Hematological Abnormalities.与血液学异常相关的新型冠状病毒2型（SARS-CoV-2）的病理效应
Curr Issues Mol Biol. 2023 Aug 28;45(9):7161-7182. doi: 10.3390/cimb45090453.
5
Differentially Expressed Inflammatory Cell Death-Related Genes and the Serum Levels of IL-6 are Determinants for Severity of Coronaviruses Diseases-2019 (COVID-19).差异表达的炎症性细胞死亡相关基因及白细胞介素-6血清水平是2019冠状病毒病（COVID-19）严重程度的决定因素。
Adv Biomed Res. 2023 Apr 27;12:102. doi: 10.4103/abr.abr_232_22. eCollection 2023.
6
Methotrexate inhibition of SARS-CoV-2 entry, infection and inflammation revealed by bioinformatics approach and a hamster model.生物信息学方法和仓鼠模型揭示甲氨蝶呤对 SARS-CoV-2 进入、感染和炎症的抑制作用。
Front Immunol. 2022 Dec 21;13:1080897. doi: 10.3389/fimmu.2022.1080897. eCollection 2022.
7
Single-cell multiomics revealed the dynamics of antigen presentation, immune response and T cell activation in the COVID-19 positive and recovered individuals.单细胞多组学揭示了 COVID-19 阳性和康复个体中抗原呈递、免疫反应和 T 细胞激活的动态变化。
Front Immunol. 2022 Dec 2;13:1034159. doi: 10.3389/fimmu.2022.1034159. eCollection 2022.
8
SARS-CoV-2 cell entry beyond the ACE2 receptor.SARS-CoV-2 细胞进入 ACE2 受体以外的途径。
Mol Biol Rep. 2022 Nov;49(11):10715-10727. doi: 10.1007/s11033-022-07700-x. Epub 2022 Jun 26.
9
Insight into prognostics, diagnostics, and management strategies for SARS CoV-2.对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的预后、诊断和管理策略的洞察。
RSC Adv. 2022 Mar 11;12(13):8059-8094. doi: 10.1039/d1ra07988c. eCollection 2022 Mar 8.
10
Hematological profiles of COVID-19 patients at the Ratlam district, Madhya Pradesh State, India.印度中央邦拉特兰地区新冠肺炎患者的血液学特征。
Bioinformation. 2021 Jul 31;17(7):686-690. doi: 10.6026/97320630017686. eCollection 2021.

本文引用的文献

1
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.淋巴细胞减少症可预测新型冠状病毒肺炎的疾病严重程度：一项描述性和预测性研究。
Signal Transduct Target Ther. 2020 Mar 27;5(1):33. doi: 10.1038/s41392-020-0148-4.